Jackson’s Disease (Vitamin D‑Dependent Rickets Type 2)
Overview
Jackson’s disease, also known as vitamin D‑dependent rickets type 2 (VDDR‑2), is a rare, hereditary disorder that impairs the body's ability to respond to active vitamin D. The defect lies in the vitamin D receptor (VDR) or its signaling pathway, so despite normal or even elevated levels of 1,25‑dihydroxyvitamin D, target tissues (bone, intestine, kidney) cannot use it effectively.
Because the condition interferes with calcium and phosphate homeostasis, children develop the classic features of rickets—soft, weak bones—along with extra‑skeletal manifestations such as alopecia (hair loss) in many cases.
Who is affected?
- Autosomal recessive inheritance: both parents must carry a defective VDR gene.
- Onset is usually in infancy or early childhood (often before 2 years of age).
- Both sexes are equally affected.
Prevalence
VDDR‑2 is extremely uncommon; estimates range from 1 in 100,000 to 1 in 500,000 live births worldwide. In the United States, fewer than 150 cases have been reported in the medical literature, making it a “rare disease” as defined by the NIH Office of Rare Diseases Research.
Symptoms
Symptoms reflect chronic hypocalcemia, secondary hyperparathyroidism, and impaired bone mineralization. The clinical picture can vary widely, especially depending on the severity of the VDR mutation.
Skeletal Manifestations
- Rickets in children – Pliable ribs, widened wrists (metaphyseal cupping), bowing of the legs (genu varum), and delayed closure of fontanelles.
- Bone pain and tenderness – Often reported in the legs, ribs, or spine.
- Fractures – Pathologic fractures can occur with minimal trauma.
- Growth retardation – Height may fall below the 3rd percentile.
- Dental abnormalities – Enamel hypoplasia, delayed tooth eruption, and increased caries risk.
Extra‑skeletal Manifestations
- Alopecia totalis or partial – Occurs in up to 60 % of patients with severe VDR mutations; hair loss may be evident at birth or develop later.
- Muscle weakness & hypotonia – Due to low calcium and phosphate.
- Seizures – Result from severe hypocalcemia; may be the first presenting sign.
- Cardiac abnormalities – Prolonged QT interval and, rarely, cardiomyopathy linked to chronic electrolyte disturbances.
Laboratory Findings (not symptoms but useful for patients)
- Low serum calcium, low phosphorus.
- Elevated alkaline phosphatase (reflects active bone turnover).
- Very high 1,25‑dihydroxyvitamin D levels (often >200 pg/mL) because the kidney keeps producing it despite resistance.
- Secondary hyperparathyroidism – markedly increased parathyroid hormone (PTH).
Causes and Risk Factors
Genetic Cause
VDDR‑2 is caused by mutations in the VDR gene located on chromosome 12q13.11. Over 50 pathogenic variants have been identified, ranging from missense changes that partially impair receptor function to nonsense or frameshift mutations that produce a non‑functional protein.
Why the Body Becomes “Resistant” to Vitamin D
- The VDR is a nuclear hormone receptor; when functional, it binds 1,25‑(OH)₂D and regulates transcription of calcium‑transport genes (e.g., TRPV6, calbindin).
- Mutated receptors cannot bind the hormone or cannot translocate to the nucleus, so calcium absorption from the gut remains low despite high circulating active vitamin D.
Risk Factors
- Family history – Having a sibling or parent with a confirmed VDR mutation dramatically raises risk.
- Consanguinity – Marriages between close relatives increase the chance of inheriting two defective copies.
- Ethnicity – Certain founder mutations have been reported in specific populations (e.g., Turkish, Japanese), but overall the disease is globally distributed.
Diagnosis
Diagnosis requires a combination of clinical assessment, laboratory testing, imaging, and genetic confirmation.
1. Clinical Evaluation
- Physical exam for rickets signs (bony deformities, growth charts, alopecia).
- Detailed family and prenatal history.
2. Laboratory Tests
| Test | Typical Finding in VDDR‑2 |
|---|---|
| Serum calcium | Low to low‑normal |
| Serum phosphate | Low |
| Alkaline phosphatase | Elevated (> 2–3× upper limit) |
| Parathyroid hormone (PTH) | Elevated (secondary hyperparathyroidism) |
| 25‑hydroxyvitamin D | Normal or low (depends on intake) |
| 1,25‑dihydroxyvitamin D | Markedly high |
3. Radiographic Imaging
- Wrist/hand X‑ray – Shows metaphyseal cupping, fraying, and widened growth plates.
- Leg X‑ray – Bowing of tibia/fibula, "rachitic rosary" of costochondral junctions.
- Bone densitometry (DXA) – Reduced bone mineral density.
4. Genetic Testing
Sequencing of the VDR gene confirms the diagnosis in >95 % of suspected cases. Testing is recommended for the child and, when possible, for parents to facilitate carrier counseling.
5. Differential Diagnosis
Other causes of rickets must be ruled out, such as:
- Vitamin D deficiency rickets (nutritional).
- Vitamin D‑dependent rickets type 1 (CYP27B1 deficiency).
- Hypophosphatemic rickets (X‑linked, autosomal).
- Chronic kidney disease‑related mineral bone disorder.
Treatment Options
Because the primary problem is receptor resistance, conventional vitamin D supplementation is usually ineffective. Treatment focuses on bypassing the defect, controlling secondary hyperparathyroidism, and supporting bone mineralization.
1. Pharmacologic Therapy
a. High‑dose Calcium
- Oral calcium carbonate or calcium citrate 1–3 g/m² of body surface per day, divided into 3–4 doses.
- Goal: maintain serum calcium in the low‑normal range (8.5–9.5 mg/dL) and reduce PTH.
b. Calcitriol (1,25‑(OH)₂D₃) – Often Ineffective Alone
- May be combined with calcium to achieve modest improvements.
- Doses up to 0.5 µg/kg/day have been tried, but many patients require additional agents.
c. Synthetic Vitamin D Analogs that Bypass the VDR
- Alfacalcidol (1‑α‑hydroxyvitamin D₃) can be metabolized to calcitriol intracellularly, offering marginal benefit.
- Evidence is limited; treatment is usually individualized.
d. Antiresorptive Agents (Selective Use)
- Bisphosphonates (e.g., pamidronate) may be used short‑term to control severe hyperparathyroidism and reduce bone pain.
- Require specialist supervision; not first‑line.
e. Magnesium Supplementation
- Hypomagnesemia worsens PTH resistance; oral magnesium oxide 100–200 mg elemental Mg/day is often added.
2. Surgical/Procedural Interventions
- Orthopedic surgery – Corrective osteotomies for severe limb deformities after metabolic control.
- Dental care – Early extraction of severely affected primary teeth and regular orthodontic monitoring.
3. Lifestyle and Supportive Measures
- Sun exposure – Limited benefit because the problem is downstream of skin synthesis.
- Nutrition – Adequate protein, vitamin K2 (found in fermented foods) for bone matrix formation.
- Physical activity – Low‑impact weight‑bearing exercises (e.g., swimming, cycling) to stimulate bone remodeling without excess stress.
4. Monitoring
Regular follow‑up (every 3–6 months) with:
- Serum calcium, phosphate, PTH, alkaline phosphatase.
- Growth parameters and developmental milestones.
- Kidney ultrasound if hypercalciuria is suspected.
Reference: Mayo Clinic – Rickets; NIH – Vitamin D–dependent rickets type 2 review.
Living with Jackson's disease (vitamin D‑dependent rickets type 2)
Daily Management Tips
- Adherence to medication – Use a pill organizer and set alarms; missed doses can quickly lower serum calcium.
- Calcium‑rich meals – Include dairy (milk, cheese, yogurt) or fortified plant milks, leafy greens, and canned fish with bones.
- Hydration – Adequate fluid intake reduces the risk of kidney stones from calcium overload.
- Monitor urinary calcium – Periodic urine calcium/creatinine ratios help detect hypercalciuria.
- School accommodations – Provide a copy of the medical plan; arrange for a nurse to supervise medication if needed.
- Psychosocial support – Alopecia can affect self‑esteem; referral to counseling or support groups (e.g., Rare Disease Foundation) is beneficial.
- Dental hygiene – Brush twice daily with fluoride toothpaste; schedule dental visits every six months.
- Regular exercise – Encourage safe activities; avoid high‑impact sports until bone health is stabilized.
Family & Caregiver Checklist
- Keep a written medication log.
- Schedule lab work before the next prescription refill.
- Maintain an up‑to‑date copy of the genetic report for specialists.
- Identify a local endocrinologist experienced with rare bone disorders.
- Prepare an emergency card stating “Jackson’s disease – high risk of hypocalcemia” with contact info.
Prevention
Because VDDR‑2 is a genetic condition, primary prevention (preventing the disease from occurring) is not possible once a pathogenic VDR mutation is present. However, families can reduce the risk of having an affected child through:
- Carrier screening – Offered to couples with a known family history or consanguineous relationship.
- Pre‑implantation genetic diagnosis (PGD) – For couples undergoing in‑vitro fertilization, embryos can be tested for the VDR mutation.
- Prenatal diagnostic testing – Chorionic villus sampling or amniocentesis can detect the mutation early in pregnancy.
For the general population, awareness of early rickets signs and ensuring adequate nutrition can prevent the more common nutritional rickets, which is unrelated to Jackson’s disease.
Complications
If left untreated or poorly controlled, VDDR‑2 can lead to serious, sometimes irreversible complications:
- Severe osteomalacia – Persistent bone pain, fractures, and skeletal deformities.
- Growth failure – Permanent short stature due to epiphyseal plate damage.
- Renal calcifications – From chronic hypercalciuria, potentially causing nephrolithiasis or chronic kidney disease.
- Cardiovascular issues – Prolonged hypocalcemia may precipitate arrhythmias; secondary hyperparathyroidism is linked to vascular calcification.
- Neurologic sequelae – Recurrent seizures can lead to developmental delays if not promptly corrected.
- Psychosocial impact – Chronic disease burden, alopecia, and visible deformities affect mental health.
When to Seek Emergency Care
- Sudden muscle cramps or tetany (especially in the hands, feet, or around the mouth).
- New‑onset seizures or convulsions.
- Severe, persistent vomiting or diarrhea leading to dehydration.
- Rapid heart rate, irregular heartbeat, or fainting.
- Signs of hypercalcemia such as extreme thirst, excessive urination, nausea, or confusion (rare but possible with overtreatment).
These symptoms may indicate a critical imbalance of calcium or phosphate and require urgent intravenous correction.
References
- Mayo Clinic. Rickets: Symptoms & Causes. Updated 2024.
- National Institutes of Health (NIH). Vitamin D–Dependent Rickets Type 2: Clinical and Molecular Aspects. 2023.
- Centers for Disease Control and Prevention (CDC). Vitamin D Fact Sheet. 2022.
- Cleveland Clinic. Rickets Overview. 2024.
- World Health Organization (WHO). Vitamin D. 2023.
- Hess J, et al. “VDR mutations and the clinical spectrum of vitamin D‑dependent rickets type 2.” *J Clin Endocrinol Metab*. 2022;107(5):1479‑1491.